Bayer | BAYN - Ebitda

Aktienkurs
38.50
Täglich Wechseln
-1.54 -3.85%
Monatlich
0.97%
Jährlich
67.46%
Q2 Prognose
40.02




Ebitda Veränderung Datum
Air Liquide EUR 3.82B 205.4M 2025-12
Akzo Nobel EUR 345M 540M 2026-03
Alcon AG USD 317M 337M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Arkema EUR 310M 54M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
BASF EUR 1.54B 228M 2025-09
Bayer EUR 1.97B 457M 2025-12
Beiersdorf EUR 984M 147M 2025-06
Corteva USD 446M 397M 2025-12
Covestro EUR 242M 24M 2025-09
Essilor EUR 3.09B 356M 2024-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Genmab DKK 186M 291M 2025-12
Givaudan CHF 778M 195M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Henkel EUR 1.88B 139M 2024-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Johnson Matthey GBP 325M 52M 2024-06
Linde USD 3.38B 30M 2025-09
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Nutrien USD 1.28B 154M 2025-12
Philips EUR 738M 9M 2025-09
PPG Industries USD 596M 163M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
SAP EUR 3.17B 606M 2026-03
Solvay EUR 169M 63M 2025-12
UCB EUR 1.6B 570M 2025-12
Umicore EUR 433M 63M 2025-06
Vinci EUR 7.83B 1.7B 2025-12